C-RAD announced today a purchase order from the
C-RAD and IBA have several successful collaborations at multiple sites globally. This latest project includes an installation at two prominent Chinese proton therapy centers.
Proton therapy and the high demands for uncompromised accuracy and operational efficiency within the field lies at the centre of technological advancement at C-RAD. One of many reasons why C-RAD is the SGRT market leader within the proton field.
The C-RAD Catalyst PT is a surface guided radiation therapy system (SGRT) version based on the patented Catalyst technology and software for use in proton and particle therapy, it is a complete solution for high precision patient positioning, intra-fraction motion management, and respiratory gating.
“I am excited to work with the customers and IBA on the implementation of our advanced surface tracking solutions here in China.” says
“We are delighted to announce this important milestone in the implementation of our strategy to make surface tracking standard of care in advanced radiation therapy.” says
The order has a total value of approximately 20 MSEK. Delivery and installation are expected to be commence during 2023.
© Modular Finance, source